January, 2014
Website Photo - Group
Society of Biological Psychiatry
"Scientists collaborating to eliminate the suffering of mental illness."
In This Issue
SOBP Vision Statement
Message from the Editor
2014 Meeting - Register Now
J of Biological Psychiatry Update
New Members Approved
Other Meetings of Interest
Get Involved
Add SOBP to your Contacts
SOBP Contact Information
SOBP Vision Statement

 The vision of the Society of Biological Psychiatry is to integrate, advance, and promulgate science relevant to psychiatric disorders, in order to reduce or prevent the suffering of people with these conditions.   

Quick Links
May 8-10, 2014  



(Receive email alerts for

content of interest to you)


In This Issue 

(A brief summary of articles in current issue)

Message from the Editor

Strakowski picture with monitor

Hello Folks,


We are once again gearing up for our annual SOBP meeting, this year in Super Bowl City, NY, NY. Hopefully, by the time of our meeting it will have warmed up a bit.   In this issue you will find many of the pertinent details to help you plan for your meeting.  Meeting registration and hotel reservations are now open.  Remember, if you can make it there, you can make it anywhere!


Also in this issue, I'm please to introduce Dr. Caleb Adler, one of our newsletter editorial board members and senior faculty at the University of Cincinnati. Cal serves on our university conflict of interest committee and has been carefully thinking about how to best manage COI without completely abandoning important industry/university relationships. Consequently, I am pleased to turn over the editorial page to his thoughts and would ask you to please consider responding to initiate a discussion in this important area.


Best Wishes

Steve Strakowski, MD
Senior Vice President of Strategic Planning and Business Development

UC Health Vice President for Research

Professor and Chair, Department of Psychiatry & Behavioral Neuroscience       



"Members, officers, and certain employees must annually disclose personal financial interests, including investments, income, and liabilities...Proposals for divestiture of potentially conflicting assets and mandatory disqualification of Members from voting were rejected as impractical or unreasonable."

       Those are lines from the website of the Committee on Ethics for the U.S. House of Representatives, one of the most powerful legislative bodies in the world, describing their view that potential conflicts-of-interest are inevitable and to a degree, acceptable. Concern with conflicts-of-interest has reached something of a fever pitch over the past decade and touched most neuroscientists to at least some degree. Of course we're not subject to congressional ethics rules; rather, we're bound by conflict-of-interest regulations promulgated by our individual academic institutions. So unlike my local congressman, I can't accept a pen that says "Zyprexa."
       Most universities maintain staff devoted to monitoring and limiting potential conflicts, while university conflict-of-interest committees rigorously enforce policies often designed to go well beyond preventing actual conflict to encompass even the "perception" of conflict-of-interest. Unfortunately, perceived conflict has followed the path trod by "dignity" in ethics; a reasonable-sounding notion that, as Ruth Macklin observed in 2003, is so vague on closer examination as to be a "useless concept" in application. Whose perception is relevant, that of colleagues, the general public, an anonymous blogger in Wisconsin?
       As a member of our university conflict of interest committee I'm certainly aware that efforts to address real conflict are necessary -- to a point. There is no question that investigators may benefit materially from certain research outcomes, and there have been several high profile incidents over the past few years in which data were found to have been faked. Few if any of those cases though, would have been prevented by the kind of conflict-of-interest regulations that have been put into place by many institutions. The pay-off to offending investigators was not a quid pro quo from a specific institution or corporation, it came in the form of academic advancement and access to research money-the coin of the realm for most academic researchers. Typical university regulations cannot police investigators determined to commit research fraud; instead, many institutions appear to operate with an implicit assumption that all investigators are only a few extra dollars away from bias.
       When questioned, the keepers of the regulatory flame point to a body of research suggesting that physicians can be influenced clinically by a cheap tchotchke, or free lunch; the inference being that bias can be unconscious and subvert even strongly held values. Putting aside the observation that these clinical findings are not necessarily applicable to a research setting, and eschewing the easy dig at the relative venality of physicians compared with PhD investigators, the studies on which this assertion is based rarely stand much scrutiny. Minor inducements, like a pharmaceutically-labeled pen that were found to influence purely theoretical prescriptive decisions by medical trainees are much less likely to influence clinicians with actual experience prescribing the relevant medications. Another study, describing increased use of a complicated medication regimen by physicians who attended a free weekend conference, didn't address the possibility that the training received might have driven the increase rather than gratitude for the getaway. In the aggregate, these often limited studies have created an echo chamber in which calls for more "action" put pressure on university conflict management departments to guard against increasingly implausible sources of bias.
       These efforts are not without consequence. Overly stringent limitations on investigators' interaction with industry have the potential to hamper important industry-academic collaborations. Given the straitened financial circumstances of granting agencies, industry funding has become increasingly important, and academic consultants can help steer research efforts in directions with the most promise for both the company and our patients. Even the much maligned speakers' bureaus can help promote contact with industry liaisons while giving community prescribers access to prominent clinician-researchers. Potential conflicts-of-interest are certainly real, and neuroscience researchers have a responsibility to the sources of our funding and to the public at large to ensure that the work we do always reflects the highest standards of probity. Punishment for those who tarnish the reputation of our field is essential, as are efforts to keep research methodologies transparent; I've met few investigators who don't agree that "sunlight is...the best of disinfectants." Nonetheless, we will not improve either our reputation or the quality of our research by acquiescing to the canard that we can be bought for a pen.

Caleb M. Adler, MD
Professor of Psychiatry and Behavioral Neuroscience
Co-Director of the Division of Bipolar Disorders Research
Director of the Center for Imaging Research
University of Cincinnati 




Disclaimer:  The opinions expressed in these editorials are those of the individual authors and do not necessarily reflect the position of the Society of Biological Psychiatry, its officers, or members.  The Society does not accept money from commercial sources, other than our business partners. 

2014 Meeting Update

Society of Biological Psychiatry's 69th Annual Meeting

May 8-10, 2014
Hilton Midtown  

New York, NY  

Special Notice:  Meeting is AFTER the APA Meeting


The development of new diagnostic biomarkers and treatments for psychiatric disorders depends on the process of scientific translation. In psychiatry, the process of scientific translation faces special obstacles because of the unique complexity of the human brain.  Nonetheless, we now have an unparalleled opportunity to overcome these obstacles, because of recent advances in neuroscience, genomics, proteomics, neuroimaging and computational biology.  Next year's program will feature plenary lectures where the process of scientific translation is deconstructed and analyzed, so that we can identify better strategies for developmental success.  The submission of regular panel sessions that focus on specific elements of the translational process are encouraged. Working together, we are poised to succeed in improving the treatment we can offer to our patients, so that they can enjoy more successful lives.    


Visit SOBP for meeting registration and hotel reservations.

Late Breaking Abstracts Opens February 3, 2014 - Link to submit will be available at that time

Join SOBP by February 1st to receive reduced registration fee to attend the 2014 annual meeting.   

Visit SOBP.ORG or email [email protected]  


Questions?  Email [email protected] or call 904-953-2842.     


Biological Psychiatry Update

Biological Psychiatry: Raising the Bar


As I detailed in my October editorial (doi:10.1016/j.biopsych.2013.07.034), Biological Psychiatry continues to thrive in its efforts to advance science and support both its authors and reviewers.

            This year, the Journal achieved an Impact Factor of 9.247, the highest in its history, ranking it 4th in Psychiatry and 13th in Neurosciences. The Journal also has an h5 of 100, the top-ranked psychiatry journal according to Google Scholar. These achievements come while our submission rate continues to steadily rise and we focus on compiling special issues on critical or controversial issues in translational neuroscience and therapeutics. As our yearly allotment of page numbers decreases, we anticipate that our acceptance rate will drop to around 10% for original research. We recognize this makes publishing in our journal more competitive, but we strive to make Biological Psychiatry the best possible venue to publish your very best research.

            We continue to take steps to increase the value of Biological Psychiatryto both authors and readers. Soon, we will begin to publish manuscripts online within days of acceptance (prior to copyediting) and copyedited manuscripts will continue to be posted online in an average of 28 days. We are also excited to introduce AudioSlides, a new and free feature that allows authors to prepare a brief, "webcast-style" presentation that appears next to their article on ScienceDirect. The Journal also now supports 3D viewer functionality, has a dedicated iPad app, and since January of this year, publishes every issue in an interactive Digital Edition format, where readers can bookmark and email favorite articles, make notes, download the entire issue into a PDF format, and even view translations of articles in over 40 different languages.

The success that we have achieved in increasing the quality and impact of Biological Psychiatry reflects its exceptional team to whom I am extremely grateful, and the unwavering support of the leadership of the Society of Biological Psychiatry. The fields of translational neuroscience and therapeutics have never been more important, more interesting, or more fun. It is a tremendous privilege to continue to shepherd Biological Psychiatry through the roiling controversies and exciting advances that shape our journal and our field. It is in this spirit of adventure that the Biological Psychiatry team and I will continue to look for new ways to raise the bar. As always, we welcome input on steps that we might take towards this end.


John Krystal, M.D.

Editor, Biological Psychiatry


New Members Effective January 1, 2014



Member Type





McLean Hospital - Harvard Medical School




University of Edinburgh




McLean Hospital/Harvard Medical School




Oxford University




Yale University




Temple University




Zucker Hillside




University of Pittsburgh








Stanford University




VA Boston Healthcare System








Ikahn School of Medicine at Mount Sinai




Universidad de Antioquia, Colombia




NYU School of Medicine




Duke University




Sheppard Pratt Health System




Insights Physicians PC




McMaster University




Semel Institute for Neuroscience and Human Behavior at UCLA




University of California, Davis Medical Center




Troy University




Emory University School of Medicine








NYU School of Medicine




The Salk Institute for Biological Studies




University of Pennsylvania




University of Colorado Denver


Other Meetings of Interest

22nd European Congress of Psychiatry 

March 1-4, 2014

Munich, Germany   


104th Annual Meeting of the American Psychopathological Association

March 6-9, 2014

Grand Hyatt, New York City  


16th Annual Conference of the International Society for Bipolar Disorders 

March 18-21, 2014

Seoul, South Korea   


Schizophrenia International Research Biennial Conference 

April 5-9, 2014

Florence, Italy    


International Society for Research on Impulsivity (InSRI) 

July 24, 2014
Cambridge, UK
Registration is now open for the annual meeting if the International Society for Research on Impulsivity.  The meeting will be July 24, 2014 as a one day satellite symposium to the British Association for Psychopharmacology Summer Meeting at in Cambridge, UK.  Discounted meeting registration and dues are $185 for regular members and $75 for trainees prior to March 31, 2014.  Meeting registration and payment of annual dues for membership can be made at
https://isri.worldsecuresystems.com/meetings/meeting-registrationThe InSRI is also accepting abstracts for poster presentations (250 word maximum).  Abstracts should be submitted by March 30, 2014 to Dr. Luke Clark at[email protected]


Bench to Bedside & Back to Bench:  Translational Bridges in Mood & Addiction 

September 4-6, 2014

Doubletree Hotel
Rochester, Minnesota
Contact:  Hailey Lalicata, [email protected], 507.293.2128 

Get Involved - Join a Committee
Did you know that 15% of our members are actively engaged on Society committees?  Want to be engaged and involved with one of our committees? Looking for a leadership opportunity?  Then signup to join one of the Society's many award committees or a task force.  Click here to tell us which groups you would be interested in joining.
SOBP Career Center
Career Image 
SOBP's Career Center connects our members with employment opportunities and employers with the best professionals within our membership. Employment opportunities range from post-doc positions, faculty positions, neuroscience jobs in industry and alternative careers.
Visit SOBP's Career Center  today to explore employment opportunities.  Post an anonymous resume for employers or recruiters to view.
Links to other resources are available for your convenience.
Add SOBP to your Contacts
Be sure to add the following email address to your address book.  To communicate quickly and efficiently with our members, all correspondence (membership renewals, newsletter, meeting announcements, etc) from the Society is sent via email.  Depending upon the type of correspondence, you may receive emails from the following addresses:

Contact Us
Society of Biological Psychiatry Business Office
4500 San Pablo Rd - Birdsall 310
Jacksonville, FL 32224
904-953-2842 Office
904-953-7117 Fax
Biological Psychiatry Editorial Office
The University of Texas Southwestern Medical Center
6363 Forest Park Rd., Suite 651
Dallas, TX 75235-5435
214-648-0880 Office
214-648-0881 Fax
Society of Biological Psychiatry Newsletter Editorial Staff 

Stephen M. Strakowski, MD, Editor

Editorial Board
Helen Mayberg, MD
William B. Lawson, MD, PhD, DLFAPA 
Alan H. Young, MD, PhD
Caleb M. Adler, MD
Join our Mailing List!